Brief: Essex Bio-Technology FY Profit HK$346 Mln
March 22 (Reuters) - Essex Bio-Technology Ltd 1061.HK :
* PROPOSE A FINAL DIVIDEND OF HK$0.055 PER ORDINARY SHARE
* FY TURNOVER HK$1.64 BILLION VERSUS HK$978.1 MILLION
* FY PROFIT HK$346 MILLION VERSUS HK$218.9 MILLION
* RECENT DEVELOPMENTS AROUND RUSSIA-UKRAINE COULD
POTENTIALLY
INDUCE DELAYS IN MITOTECH'S VISTA CLINICAL TRIAL PROGRAMME
Further company coverage: 1061.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Essex Bio-Technology
See all newsHong Kong's Essex Bio-Technology H1 revenue falls
Brief: Essex Bio-Technology Posts HY Profit Of HK$110.7 MLN
Brief: Essex Bio-Technology Expects 10% Revenue And 30% Profit Decrease For HY
Brief: Shanghai Henlius Biotech Says Phase 3 Study Of HLX04-O For WAMD Meets Primary Endpoint
Brief: Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share